World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
45
Citations
5661
World Ranking
5065
National Ranking
1950

Best Publications

  • Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates

    Emily P. Thi;Chad E. Mire;Amy C. H. Lee;Joan B. Geisbert

  • Mutual Antagonism between the Ebola Virus VP35 Protein and the RIG-I Activator PACT Determines Infection Outcome

    Priya Luthra;Parameshwaran Ramanan;Parameshwaran Ramanan;Chad E. Mire;Carla Weisend

  • Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy.

    Chad E. Mire;Benjamin A. Satterfield;Joan B. Geisbert;Krystle N. Agans

  • Therapeutic Treatment of Nipah Virus Infection in Nonhuman Primates with a Neutralizing Human Monoclonal Antibody

    Thomas W. Geisbert;Chad E. Mire;Joan B. Geisbert;Yee Peng Chan

  • The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses

    Eve Isabelle Pécheur;Viktoriya Borisevich;Peter Halfmann;John D. Morrey

  • A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses.

    David Safronetz;Chad Mire;Kyle Rosenke;Friederike Feldmann

  • Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever

    Chad E Mire;Robert W Cross;Joan B Geisbert;Viktoriya Borisevich

  • The Marburg Virus VP24 Protein Interacts with Keap1 to Activate the Cytoprotective Antioxidant Response Pathway.

    Megan R. Edwards;Britney Johnson;Chad E. Mire;Wei Xu

  • Post-exposure treatments for Ebola and Marburg virus infections

    Robert W. Cross;Chad E. Mire;Heinz Feldmann;Thomas W. Geisbert

  • Lead Precipitation by Vibrio harveyi: Evidence for Novel Quorum-Sensing Interactions

    Chad E. Mire;Jeanette A. Tourjee;William F. O'Brien;William F. O'Brien;Kandalam V. Ramanujachary

  • The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus.

    Luke D. Jasenosky;Cristhian Cadena;Chad E. Mire;Viktoriya Borisevich

  • Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus

    Chad E. Mire;Demetrius Matassov;Joan B. Geisbert;Theresa E. Latham

  • The immunomodulating V and W proteins of Nipah virus determine disease course.

    Benjamin A. Satterfield;Robert W. Cross;Karla A. Fenton;Krystle N. Agans

  • An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections

    Ha V. Dang;Yee Peng Chan;Young Jun Park;Joost Snijder;Joost Snijder

  • A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates

    Benoit Callendret;Jort Vellinga;Kerstin Wunderlich;Ariane Rodriguez

  • A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates

    Zachary A. Bornholdt;Andrew S. Herbert;Chad E. Mire;Shihua He

  • The Domestic Ferret (Mustela putorius furo) as a Lethal Infection Model for 3 Species of Ebolavirus.

    Robert W. Cross;Chad E. Mire;Viktoriya Borisevich;Joan B. Geisbert

  • Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody

    Chad E. Mire;Joan B. Geisbert;Viktoriya Borisevich;Karla A. Fenton

  • Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA

    Emily P. Thi;Chad E. Mire;Raul Ursic-Bedoya;Joan B. Geisbert

  • Differential regulation of interferon responses by Ebola and Marburg virus VP35 proteins

    Megan R. Edwards;Megan R. Edwards;Gai Liu;Chad E. Mire;Suhas Sureshchandra

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Recently Published Articles